idiopathic pulmonary fibrosis

News

Clear COVID health information essential for a return to healthcare as normal

Pharma poised to cash in on 'long COVID' symptoms

While there’s hope that vaccination campaigns may bring the pandemic under control, “long COVID” side effects may continue to affect patients for some time.

News

Gilead/Galapagos alliance hit again as IPF drug is binned

Gilead and Galapagos' much-trumpeted R&D alliance has suffered another setback with the abandonment of ziritaxestat after a late-stage failure in idiopathic pulmonary fibrosis (IPF).

News

Boehringer Ingelheim, Biberach, Germany, February 2007

Boehringer axes IPF deal with South Korea's Bridge Biotherap...

Boehringer Ingelheim and South Korea’s Bridge Biotherapeutics have decided to axe their collaboration over a potential new drug for idiopathic pulmonary fibrosis (IPF), BBT-877.

News

Galecto raises $64m to finance EU filing for inhaled IPF dru...

Privately-held biotech Galecto has raised $64m with an equity funding round to further research into treatments for drugs including a potential inhaled idiopathic pulmonary fibrosis (IPF) m

News

Redx shares soar after IPF drug licence deal with AstraZenec...

Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to AstraZeneca.

News

Roche increases IPF presence with $1.39bn Promedior buy

Roche has agreed to buy US biotech Promedior, and a portfolio of drugs including a promising molecule for the deadly lung-scarring disease idiopathic pulmonary fibrosis (IPF) in a deal wort

Pharma poised to cash in on 'long COVID' symptoms

Gilead/Galapagos alliance hit again as IPF drug is binned

Boehringer axes IPF deal with South Korea's Bridge Biotherap...

Galecto raises $64m to finance EU filing for inhaled IPF dru...

Redx shares soar after IPF drug licence deal with AstraZenec...

Roche increases IPF presence with $1.39bn Promedior buy

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

idiopathic pulmonary fibrosis

Editor's Picks